Abituzumab - HY-P99183
Nur noch %1 verfügbar
Catalog #
HY-P99183
Ab
295,00 €
Abituzumab (DI17E6) is a humanised anti-integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99183/Abituzumab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | Cancer-Kinase/protease |
| Alternative Names | EMD 525797; DI17E6 |
| CAS | 1105038-73-0 |
| Storage | Store at -80°C for 2 years |
| MWT | N/A |
| Solubility | 10 mM in DMSO |
| Clinical Information | Phase 2 |
| Pathway | Cytoskeleton |
| Target | Integrin |
| Application: | Cancer-Kinase/protease |
|---|